Pms-fluoxetine: Affected Lots Exceed The Interim Acceptable Intake Limit For N-nitroso-fluoxetine.
Recall Summary PMS-FLUOXETINE tablets are being recalled across Canada because certain batches contain higher-than-acceptable levels of N-nitroso-fluoxetine, a potentially harmful impurity. This is a Class I recall, meaning the product poses a serious health risk. The recall affects all PMS-FLUOXETINE products distributed in Canada.
- Product
- PMS-FLUOXETINE
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-04-28
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/7e147b59-dbaf-4a0b-b09b-f5d0bda02db6